Clinical Trial Update: Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating lenalidomide in patients with multiple myeloma undergoing autologous stem cell transplant; status ACTIVE_NOT_RECRUITING…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: DS Stage I Multiple Myeloma, DS Stage II Multiple Myeloma | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2013-07-01